experspadmin

Low-Dose Interleukin 2 and Its Potential in Systemic Lupus Erythematosus
Rheumatology

Low-Dose Interleukin 2 and Its Potential in Systemic Lupus Erythematosus

patient care perspectives
By George C. Tsokos, MD
Interferon-Blocking Strategies in Systemic Lupus Erythematosus Research
Rheumatology

Interferon-Blocking Strategies in Systemic Lupus Erythematosus Research

clinical topic updates
By Joan T. Merrill, MD
Progression on Targeted Therapy for Non–Small Cell Lung Cancer: Best Practices
Oncology

Progression on Targeted Therapy for Non–Small Cell Lung Cancer: Best Practices

patient care perspectives
By Gregory J. Riely, MD, PhD
Targeted Biologic Therapy in Systemic Lupus Erythematosus
Rheumatology

Targeted Biologic Therapy in Systemic Lupus Erythematosus

expert roundtables
By Bevra H. Hahn, MD; George C. Tsokos, MD; Joan T. Merrill, MD
Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Rheumatology

Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

expert roundtables
By Bevra H. Hahn, MD; George C. Tsokos, MD; Joan T. Merrill, MD
Load More